Timothée Olivier, MD retweetledi
Is there any better way to start the day than dissecting such a controversial trail at our journal club ? @apmariniello @PTarantinoMD @Timothee_MD
English
Timothée Olivier, MD
2.4K posts
Timothée Olivier, MD
@Timothee_MD
Oncology (sarcoma, H&N, CUP). EBM, Health Policy @HUG_ge (Geneva), @vkprasadlab (UCSF). Geneva Ethics Committee. Co-EiC ESMO Rare Cancers. No COI. Views mine.
Genève, Suisse Katılım Aralık 2021
417 Takip Edilen2.8K Takipçiler
Timothée Olivier, MD retweetledi
The Imbalance of Cancer Guidelines: Quick to Implement, Slow to Let Go
theoncologyshot.com/p/the-imbalanc… via @ChrisRios6 & @Timothee_MD @Maherjane @DrMarkLythgoe
English
Timothée Olivier, MD retweetledi
This is one of the best pieces I’ve read in a long time. Many thanks to @anish_koka for this superb piece and thoughtful recounting. Those who really know @VPrasadMDMPH know he will do even more good and rise even higher.
Anish Koka, MD@anish_koka
English
Timothée Olivier, MD retweetledi
It shocks me that those who holler about disparities of US healthcare and its outlandish costs are happy that pharma $$ ousted a person interested in preserving value. Just shocking. @VPrasadMDMPH we are happy to have you back at @Sensible__Med
English
Timothée Olivier, MD retweetledi
Timothée Olivier, MD retweetledi
"Critical Appraisal in Breast Cancer: The Essentials in 30 Minutes."
My full talk here: theoncologyshot.com/p/critical-app…
English
Timothée Olivier, MD retweetledi
Three weeks later, @WSJ finally corrects a vicious allegation of sexual harassment by @VPrasadMDMPH at @US_FDA
English
Timothée Olivier, MD retweetledi
Timothée Olivier, MD retweetledi
Critical Appraisal in Breast Cancer: The Essentials in 30 Minutes.
theoncologyshot.com/p/critical-app… via @Timothee_MD
English
Critical appraisal in Breast Cancer: The Essentials in 30 minutes!
My full talk at Swiss Academy Multidisciplinary Oncology (SAMO) available at "The Oncology Shot"!
Here is an excerpt: contextualizing the survival gain reported in MonarchE = 2 years of adjuvant abemaciclib
English
Timothée Olivier, MD retweetledi
You can fuss about the framing but this is NOT misinformation. See bmjopen.bmj.com/content/5/9/e0…
AM is really close to correct. Survival (on average) is smaller than you think
Even the ICD vs amio for sustained VT is months not years. In the old days authors stated it clearly
Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦@DrMarthaGulati
It’s very sad when a cardiologist spreads misinformation on a medication that has and can save lives. Getting attention seems more important to this guy than saving hearts & lives.
English
Timothée Olivier, MD retweetledi
Timothée Olivier, MD retweetledi
There’s a familiar behavioral pattern here, and it sits close to the heart of why trust in science media is eroding.
You critique behavior in rational terms, and instead of engaging the substance, the response is to imply something is wrong with you. It’s a classic deflection — shifting from ideas to emotion and pathologizing the critic.
That kind of gaslighting is coming from a senior reporter at a major biotech and pharma outlet, which raises a larger question: if this is how dissent is handled publicly, what does that say about the integrity of the reporting behind the scenes?
Many have suggested I just block him or ignore. But I continue to mention it because it’s about documenting a major problem. When journalists covering science respond to critique with mockery instead of argument, it reflects on the institutions they represent.
Adam Feuerstein ✡️@adamfeuerstein
@LocasaleLab Jason, do you need a hug?
English
Timothée Olivier, MD retweetledi
Though it is tempting, I won't sink to ad hominems as you routinely do
My relevance is apparent to the thousands patients I have cared for, and the dozens of mentees I have taught and supported, not to mention the important scientific work I have done
Adam Feuerstein ✡️@adamfeuerstein
@venkmurthy Venk with the spin! Predictable. Also, love your posts, keep at it. One day, you might even become semi-relevant.
English
Timothée Olivier, MD retweetledi
Academia: FDA needs reform
FDA: cool. let's elevate standards
Academics: whoa you can't change things so quickly!
English
I really like this quote from a recent @adamfeuerstein’s piece:
"Prasad changed jobs but his conservative regulatory doctrine remains the same, particularly for cell and gene therapies. The approval bar is much higher than it ever was before."
Keep the great work @VPrasadMDMPH !
English
Timothée Olivier, MD retweetledi
We can debate the right approach to plotting small absolute difference should be
Its crossing lines to question @drjohnm credentials as a physician because he came to a different conclusion on how a y-axis should be constructed
That ad hominem reveals more about the ones using it rather than @drjohnm
Michael Albert, MD@MichaelAlbertMD
I agree that John has said many valuable things, but we should not be afraid to be appropriately critical when colleagues get something wrong. In this case, there is nothing inherently wrong with the y axis representation, despite John’s view that it might discredit VP’s actions. Anyone can be wrong, including the best of us. Our fear of being wrong, as though it diminishes us, is part of the social media problem. I will be the first to admit that I am often wrong or imprecise. I wish more of us were comfortable admitting this.
English